CMRE vs GRC

CMRE presents a classic deep-value profile, trading significantly below its Graham Number ($34.68) and Intrinsic Value ($91.16) with a very low P/E of 5.34. While the Piotroski F-Score of 4/9 indicates stable but mediocre financial health, the company maintains strong profitability margins (41.53%) and a conservative payout ratio. However, the outlook is clouded by a severe decline in quarterly revenue (-61.35% Q/Q) and a highly bearish technical trend (10/100). The disconnect between massive valuation discounts and deteriorating top-line growth suggests a potential value trap.

GRC exhibits strong fundamental health with a Piotroski F-Score of 7/9 and excellent liquidity (Current Ratio 2.93), though an Altman Z-Score was not provided. While earnings growth is explosive at 46.6% YoY, the stock is trading at a significant premium to its Graham Number ($28.54) and above its growth-based intrinsic value ($66.08). The massive 1-year price surge of 117% has pushed the valuation to a point where the PEG ratio (2.55) suggests the stock is overextended. Consequently, while the business is high-quality, the current entry point is risky.